- Cipla has announced that it received final approval from the USFDA for its New Drug Application for Nilotinib Capsules.
- The approval was granted on 19th February 2025.
- Nilotin…
Join the vibrant privacy-ensured Dzambhala community on
Want to give feedback on this story? Write to us at [email protected]